Literature DB >> 30002202

Biochemical Markers of Bone Turnover and Risk of Incident Diabetes in Older Women: The Cardiovascular Health Study.

Daniele Massera1, Mary L Biggs2, Marcella D Walker3, Kenneth J Mukamal4, Joachim H Ix5, Luc Djousse6, Rodrigo J Valderrábano7, David S Siscovick8, Russell P Tracy9, Xiaonan Xue1, Jorge R Kizer10.   

Abstract

OBJECTIVE: To investigate the relationship of osteocalcin (OC), a marker of bone formation, and C-terminal cross-linked telopeptide of type I collagen (CTX), a marker of bone resorption, with incident diabetes in older women. RESEARCH DESIGN AND METHODS: The analysis included 1,455 female participants from the population-based Cardiovascular Health Study (CHS) (mean [SD] age 74.6 [5.0] years). The cross-sectional association of serum total OC and CTX levels with insulin resistance (HOMA-IR) was examined using multiple linear regression. The longitudinal association of both markers with incident diabetes, defined by follow-up glucose measurements, medications, and ICD-9 codes, was examined using multivariable Cox proportional hazards models.
RESULTS: OC and CTX were strongly correlated (r = 0.80). In cross-sectional analyses, significant or near-significant inverse associations with HOMA-IR were observed for continuous levels of OC (β = -0.12 per SD increment; P = 0.004) and CTX (β = -0.08 per SD; P = 0.051) after full adjustment for demographic, lifestyle, and clinical covariates. During a median follow-up of 11.5 years, 196 cases of incident diabetes occurred. After full adjustment, both biomarkers exhibited inverse associations with incident diabetes (OC: hazard ratio 0.85 per SD [95% CI 0.71-1.02; P = 0.075]; CTX: 0.82 per SD [0.69-0.98; P = 0.031]), associations that were comparable in magnitude and approached or achieved statistical significance.
CONCLUSIONS: In late postmenopausal women, lower OC and CTX levels were associated with similarly increased risks of insulin resistance at baseline and incident diabetes over long-term follow-up. Further research to delineate the mechanisms linking abnormal bone homeostasis and energy metabolism could uncover new approaches for the prevention of these age-related disorders.
© 2018 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30002202      PMCID: PMC6105330          DOI: 10.2337/dc18-0849

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  41 in total

Review 1.  Association of serum total osteocalcin with type 2 diabetes and intermediate metabolic phenotypes: systematic review and meta-analysis of observational evidence.

Authors:  Setor Kwadzo Kunutsor; Tanefa Antoinette Apekey; Jari Antero Laukkanen
Journal:  Eur J Epidemiol       Date:  2015-06-18       Impact factor: 8.082

2.  Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

Authors:  Russel Burge; Bess Dawson-Hughes; Daniel H Solomon; John B Wong; Alison King; Anna Tosteson
Journal:  J Bone Miner Res       Date:  2007-03       Impact factor: 6.741

3.  A reduced serum level of total osteocalcin in men predicts the development of diabetes in a long-term follow-up cohort.

Authors:  Chardpraorn Ngarmukos; La-or Chailurkit; Suwanee Chanprasertyothin; Bunlue Hengprasith; Piyamitr Sritara; Boonsong Ongphiphadhanakul
Journal:  Clin Endocrinol (Oxf)       Date:  2012-07       Impact factor: 3.478

4.  Estimating glomerular filtration rate from serum creatinine and cystatin C.

Authors:  Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

Review 5.  Physiology of bone loss.

Authors:  Bart L Clarke; Sundeep Khosla
Journal:  Radiol Clin North Am       Date:  2010-05       Impact factor: 2.303

6.  In vivo analysis of the contribution of bone resorption to the control of glucose metabolism in mice.

Authors:  Julie Lacombe; Gerard Karsenty; Mathieu Ferron
Journal:  Mol Metab       Date:  2013-08-15       Impact factor: 7.422

7.  Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials.

Authors:  Ann V Schwartz; Anne L Schafer; Andrew Grey; Eric Vittinghoff; Lisa Palermo; Li-Yung L Lui; Robert B Wallace; Steven R Cummings; Dennis M Black; Douglas C Bauer; Ian R Reid
Journal:  J Bone Miner Res       Date:  2013-06       Impact factor: 6.741

8.  Measures of Body Size and Composition and Risk of Incident Atrial Fibrillation in Older People: The Cardiovascular Health Study.

Authors:  Maria G Karas; Laura M Yee; Mary L Biggs; Luc Djoussé; Kenneth J Mukamal; Joachim H Ix; Susan J Zieman; David S Siscovick; John S Gottdiener; Michael A Rosenberg; Richard A Kronmal; Susan R Heckbert; Jorge R Kizer
Journal:  Am J Epidemiol       Date:  2016-05-05       Impact factor: 4.897

9.  Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin.

Authors:  C M Gundberg; S D Nieman; S Abrams; H Rosen
Journal:  J Clin Endocrinol Metab       Date:  1998-09       Impact factor: 5.958

10.  Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.

Authors: 
Journal:  Lancet       Date:  2016-04-06       Impact factor: 79.321

View more
  6 in total

1.  FSH may mediate the association between HbA1c and bone turnover markers in postmenopausal women with type 2 diabetes.

Authors:  Ke-Xi Zha; Zeng-Mei An; Shao-Hong Ge; Jian Cai; Ying Zhou; Rong Ying; Ji Zhou; Tao Gu; Hui Guo; Yan Zhao; Ning-Jian Wang; Ying-Li Lu
Journal:  J Bone Miner Metab       Date:  2022-01-21       Impact factor: 2.626

Review 2.  Impact of Diabetes Mellitus on Bone Health.

Authors:  Cliodhna E Murray; Cynthia M Coleman
Journal:  Int J Mol Sci       Date:  2019-09-30       Impact factor: 5.923

3.  Association of Insulin Resistance and β-cell Function With Bone Turnover Biomarkers in Dysglycemia Patients.

Authors:  Hui Guo; Chiyu Wang; Boren Jiang; Shaohong Ge; Jian Cai; Ying Zhou; Rong Ying; Kexi Zha; Ji Zhou; Ningjian Wang; Chunfang Zhu; Chenyu Cao; Liqin Zhang; Tao Gu; Yan Zhao; Yingli Lu; Zengmei An
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-25       Impact factor: 5.555

Review 4.  The Role of Bone-Derived Hormones in Glucose Metabolism, Diabetic Kidney Disease, and Cardiovascular Disorders.

Authors:  Yuichi Takashi; Daiji Kawanami
Journal:  Int J Mol Sci       Date:  2022-02-21       Impact factor: 5.923

5.  Osteocalcin and Risks of Incident Diabetes and Diabetic Kidney Disease: A 4.6-Year Prospective Cohort Study.

Authors:  Xiaoqi Ye; Rong Yu; Fusong Jiang; Xuhong Hou; Li Wei; Yuqian Bao; Weiping Jia
Journal:  Diabetes Care       Date:  2022-04-01       Impact factor: 19.112

6.  Consistently Low Levels of Osteocalcin From Late Pregnancy to Postpartum Are Related to Postpartum Abnormal Glucose Metabolism in GDM Patients.

Authors:  Yujia Gong; Na Li; Mengyu Lai; Fang Fang; Jiaying Yang; Mei Kang; Tingting Shen; Yongde Peng; Yufan Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-07       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.